The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders
Equity raise to finance growth and investments in the biological space
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Since its inception, the company has either acquired or taken a majority stake in five companies
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Subscribe To Our Newsletter & Stay Updated
